儿童桥本氏甲状腺炎并发甲状腺功能减退继发肝、肾、骨骼肌损害1例报告*

doi:10.3969/j.issn.1672-5069.2023.06.040

Abstract

Yang Ruixu, Yan Shiyan, Xu Zhengjie, et al. Liver, kidney, and skeletal muscle injury induced by Hashimoto's thyroiditis and hypothyroidism: a long-term follow-up of a childhood[J]. Journal of Practical Hepatology, 2023, 26(6): 927-929.

References

[1] Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev, 2014, 13(4-5): 391-397.
[2] Cardenas-Roldan J, Rojas-Villarraga A, Anaya JM. How do autoimmune diseases cluster in families? A systematic review and meta-analysis. BMC Med, 2013, 11: 73.
[3] Mclachlan SM, Nagayama Y, Pichurin PN, et al. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology, 2007, 148(12): 5724-5733.
[4] Kraiem Z, Baron E, Kahana L, et al. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo- to hyper-thyroidism and back to hypothyroidism. Clin Endocrinol (Oxf), 1992, 36(2): 211-214.
[5] Huang MJ, Liaw YF. Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol, 1995, 10(3): 344-350.
[6] Laukkarinen J, Sand J, Autio V, et al. Bile duct stone procedures are more frequent in patients with hypothyroidism. A large, registry-based, cohort study in Finland. Scand J Gastroenterol, 2010, 45(1): 70-74.
[7] Bano A, Chaker L, Plompen EP, et al. Thyroid function and the risk of nonalcoholic fatty liver disease: The Rotterdam Study. J Clin Endocrinol Metab, 2016, 101(8): 3204-3211.
[8] Tahara K, Akahane T, Namisaki T, et al. Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease. JGH Open, 2020, 4(3): 400-404.
[9] Kim D, Vazquez-Montesino LM, Escober JA, et al. Low thyroid function in nonalcoholic fatty liver disease is an independent predictor of all-cause and cardiovascular mortality. Am J Gastroenterol, 2020, 115(9): 1496-1504.
[10] 林苏, 陈靖, 董菁, 等. 甲状腺功能减退症患者非酒精性脂肪肝的初步调查. 实用肝脏病杂志, 2009, 12(4): 274-276,287.
[11] 许炎煌, 范建高. 甲状腺激素及其类似物治疗非酒精性脂肪性肝炎的研究进展. 肝脏, 2020, 25(11): 1142-1144.
[12] Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med, 2010, 123(2): 183 e181-189.
[13] Nobili V, Liaskos C, Luigi G, et al. Autoimmune thyroiditis associated with autoimmune hepatitis. Thyroid, 2005, 15(10): 1193-1195.
[14] Duyff RF, Van Den Bosch J, Laman DM, et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiat, 2000, 68(6): 750-755.
[15] Serranti D, Indolfi G, Bartolini E, et al. Raised serum aminotransferase levels and muscle pseudohypertrophy caused by hypothyroidism. J Pediatr Gastroenterol Nutr, 2013, 56(6): e48-49.
[16] Kreisman SH, Hennessey JV. Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med, 1999, 159(1): 79-82.
[17] Saini V, Yadav A, Arora MK, et al. Correlation of creatinine with TSH levels in overt hypothyroidism - a requirement for monitoring of renal function in hypothyroid patients? Clin Biochem, 2012, 45(3): 212-214.
[18] Saha A, Bagri N, Mehera N, et al. Membranoproliferative glomerulonephritis associated with autoimmune thyroiditis. J Pediatr Endocrinol Metab, 2011, 24(9-10): 789-792.
[19] Ardalan MR, Ghabili K, Mirnour R, et al. Hypothyroidism-induced rhabdomyolysis and renal failure. Ren Fail, 2011, 33(5): 553-554.

Liver, kidney, and skeletal muscle injury induced by Hashimoto's thyroiditis and hypothyroidism: a long-term follow-up of a childhood

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yang Kaining, Wang Mengmeng, Wang Zhankun, et al. Combination of glutathione and tiopronin in the treatment of patients with drug-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(6): 839-842.
[2]	Li Ling, He Xiaoqi, Gao Yong, et al. Serum miR-21, Nrf2 and HO-1 level changes in pregnant women with drug-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(5): 662-665.
[3]	Mo Junqiao, Lin Jing, Yang Li. Improvement of liver function tests by silibinin and polyene phosphatidylcholine combination therapy in patients with anti-tuberculosis drugs-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(5): 666-669.
[4]	Pei Sujuan, Guo Jinhui, Wei Xiaoxia. Common medicines and influencing factors on severity of liver injury in hospital stay patients with drug-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(5): 670-673.
[5]	Zhang Mi, Hu Guihua, Zou Pengcheng. Changes of serum and urine NGAL, IGFBP7 and TIMP-2 levels in patients with hepatitis B liver cirrhosis complicated with acute kidney injury [J]. Journal of Practical Hepatology, 2023, 26(5): 690-693.
[6]	Gui Fenfen, Zhou Jiebin. Micro RNAs as biomarkers in patients with drug-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(5): 761-764.
[7]	Fang Shanshan, Du Mingqiao, Wang Yue. Will the hypopituitarism lead to the occurrence of nonalcoholic fatty liver diseases? An preliminary study [J]. Journal of Practical Hepatology, 2023, 26(4): 504-507.
[8]	Fu Xinyin, Lin Xiaoru, Zheng Xiufen, et al. Comparison of clinical features of patients with drug-induced autoimmune hepatitis, autoimmune hepatitis and drug-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(4): 512-515.
[9]	Tang Xinhua, Tang Huijing, Huang Chengjun, et al. Preventive effect of entecavir on anti-tuberculosis drug-induced liver injury in patients with pulmonary tuberculosis and serum HBeAg-positive high HBV loads [J]. Journal of Practical Hepatology, 2023, 26(4): 516-519.
[10]	Wang Junhong, Dai Ling, Chen Guobin, et al.. Cost-effectiveness analysis of reduced glutathione,diammonium glycyrrhizinate and glycyrrhizin in the treatment of patients with anti-tuberculosis medicine-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(3): 380-383.
[11]	Yang Kaining, Wang Mengmeng, Chen Xiuxiu et al.. Decreased incidences of drug-induced liver injury in patients with tubercular pleurisy and/or pulmonary tuberculosis during anti-tubercular therapy [J]. Journal of Practical Hepatology, 2023, 26(3): 384-387.
[12]	Wei Dongping, Han Lili, Ling Jiahui, et al.. Efficacy of glycyrrhizic acid diamine and compound glycyrrhizin in the treatment of patients with cyclophosphamide-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(3): 388-391.
[13]	Liu Lingyu, Wang Wei, Tang Jiamei. Application of ultrasound three-dimensional speckle tracking imaging in the early diagnosis of cirrhotic cardiomyopathy in patients with decompensated cirrhosis [J]. Journal of Practical Hepatology, 2023, 26(3): 400-403.
[14]	Shi Haitao, Lu Xiaolan. Portal vein thrombosis and hepatic arterio-portal fistula: a re-conceptualization of the diagnosis and treatment [J]. Journal of Practical Hepatology, 2023, 26(2): 160-163.
[15]	Wang Yan, Zhou Jing, Han Jun. Clinicopathological features of patients with autoimmune hepatitis and drug-induced liver injury [J]. Journal of Practical Hepatology, 2023, 26(2): 218-221.